Discovery Experimental & Development Inc. (DEDI)

Please Select A Category

How Liquid Deprenyl Citrate (LDC) Was Developed - Page 2

Once scientists learned how to "man-make" so to speak, ascorbic acid or Vitamin C, they now needed to separate the L side, which was the active side, from the D side which appeared to have no benefit at all.

Vitamin C was now man-made and no longer needed to be extracted from grapefruit and other food products. Now the challenge was, just how pure was the industry going to make the L-Ascorbic Acid for human consumption. The answer from the industry was purely money. It's more expensive to produce a pure product than a not so pure product. Most every chemical company that produced Vitamin C or L Ascorbic Acid produced it at a purity of between 87 - 95% pure. They then sold it to vitamin companies to add ingredients called pill fillers, to make pills and sell it to the public as Vitamin C.

Only one company that Kimball is aware of in the world produces L Ascorbic Acid at 99% purity, or above. The companies that tablet Vitamin C do not use the higher purity Vitamin C, because it costs a little more to purchase. However, in tests, the higher purity Vitamin C at 99% was 15 to 20 times more effective than all the other vitamin C products being produced. The cost however was only 4 times more for the higher priced Vitamin C product. It would actually be cheaper for the public to purchase the purer Vitamin C, simply because they would be taking 15-20 times less, while receiving better benefits from the purer product.

For your information the only company in the world that Kimball knows producing L-Ascorbic Acid or Vitamin C at 99% purity and above is located in one faraway country outside of the United States.

There is only one company Kimball knows of that actually purchases L-Ascorbic Acid at +99% purity; re-crystallizes the L-Ascorbic Acid to gain even a higher purity level; places the extreme high purity L-Ascorbic Acid in a capsule without any fillers and sells the Vitamin C to the public and doctors.

Kimball cannot disclose the name of the company doing this; simply because, the US Government would construe the Vitamin C being sold currently as a drug. This due to the content on this website stating how effective properly made L-Ascorbic Acid or Vitamin C is, in treating and preventing heart disease and cancer. You may review the effectiveness in the use of high potency Vitamin C under Cancer - Is There A Cure? and also FDA - Death By Deprivation where it talks about the fact, high potency Vitamin C is extremely effective in treating and preventing heart disease.

Vitamin C, LDC, And Selegiline HCL Similarities

Aforestated Liquid Deprenyl Citrate (LDC) is very similar to Vitamin C. Selegiline HCL which was developed in Budapest had a L side - minus, and a D side - plus. The Selegiline HCL that appeared to be effective in neurological disease was the L side while the D side appeared to do nothing at all.

Selegiline was made from an extract of a plant, which was eventually turned into a man-made product the same as Vitamin C.

Learning About The Dangerous Drug Eldepryl

At the time DEDI was attempting to develop a product similar to Selegiline HCL, the FDA had approved a prescription drug called Eldepryl. Eldepryl was FDA approved to be used only with another very dangerous prescription drug called Levodopa, which had very serious side effects. The combination of those two drugs were approved by the FDA only to be used together for patients that were afflicted with one terminal disease: Parkinson.

One of the very first things DEDI did was to take the drug "Eldepryl" apart in 1990. DEDI found Eldepryl was not a pure product and contained contaminants from 1 - 2 %. The FDA was informed of the contaminants but didn't care. Dr. Barltrop who was working with Dr. Owen for Discovery Experimental (DEDI), on the Selegiline HCL project, called the Eldepryl product rubbish.

Dr. Barltrop was a lecturer and faculty member at Oxford University in England. Dr. Barltrop was assisting Dr. Owen who was head of the organic chemistry department at the university of South Florida. Dr. Owen was in charge of the development of a Selegiline or similar product for DEDI.

When the product containing Selegiline HCL was developed in Budapest the scientist which developed the product called it "Deprenyl." DEDI had no idea exactly how pure, or exactly everything the Deprenyl product contained.

What DEDI did find out, is that the drug Eldepryl FDA approved to use only with another dangerous drug was manufactured in Budapest, Hungary, and was rubbish. It wasn't until 1994 that DEDI found out just how dangerous a product Selegiline HCL was when human trials in England were released revealing that the exact combination the FDA had approved for Parkinson patients to take (Selegiline HCL and Levodopa) killed patients at a much higher rate than patients using Levodopa by itself.